HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

pegvisomant/placebo loading dose 80mg sc, thereafter 20mg daily for 2 weeks

TERMINATED · NA · Severe Adult Growth Hormone Deficiency

recruitment completed

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.